FLOT1
Basic information
Region (hg38): 6:30727709-30742732
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FLOT1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 19 | 19 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 0 | 0 |
Variants in FLOT1
This is a list of pathogenic ClinVar variants found in the FLOT1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-30728136-T-G | not specified | Uncertain significance (May 30, 2024) | ||
6-30728145-C-A | not specified | Uncertain significance (Jun 23, 2023) | ||
6-30730033-T-C | not specified | Uncertain significance (Jul 20, 2021) | ||
6-30730469-C-T | not specified | Uncertain significance (Oct 12, 2022) | ||
6-30730522-C-A | not specified | Uncertain significance (Jul 31, 2023) | ||
6-30730547-C-T | not specified | Uncertain significance (Sep 22, 2021) | ||
6-30730921-C-A | not specified | Uncertain significance (Dec 20, 2023) | ||
6-30730941-C-T | not specified | Uncertain significance (Jun 25, 2024) | ||
6-30730962-C-T | not specified | Uncertain significance (Nov 01, 2022) | ||
6-30731049-C-T | not specified | Uncertain significance (Nov 21, 2022) | ||
6-30740181-C-A | not specified | Uncertain significance (Nov 09, 2023) | ||
6-30740189-C-T | not specified | Uncertain significance (Nov 05, 2021) | ||
6-30740192-C-T | not specified | Uncertain significance (Mar 20, 2024) | ||
6-30740205-C-T | not specified | Uncertain significance (Jun 03, 2022) | ||
6-30740213-T-C | not specified | Uncertain significance (Oct 06, 2022) | ||
6-30740247-C-A | not specified | Uncertain significance (Jul 26, 2022) | ||
6-30740512-C-T | not specified | Uncertain significance (Sep 25, 2024) | ||
6-30740536-C-T | not specified | Uncertain significance (May 31, 2023) | ||
6-30740729-T-C | not specified | Uncertain significance (Oct 25, 2023) | ||
6-30741269-G-A | not specified | Uncertain significance (Dec 14, 2022) | ||
6-30741280-G-C | not specified | Uncertain significance (Mar 28, 2024) | ||
6-30741294-C-T | not specified | Uncertain significance (Aug 12, 2024) | ||
6-30741645-C-A | not specified | Uncertain significance (Oct 25, 2023) | ||
6-30741843-A-C | not specified | Uncertain significance (Dec 07, 2021) | ||
6-30741861-C-T | not specified | Uncertain significance (Mar 20, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FLOT1 | protein_coding | protein_coding | ENST00000376389 | 12 | 15025 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.04e-8 | 0.927 | 125718 | 0 | 30 | 125748 | 0.000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.34 | 150 | 255 | 0.587 | 0.0000147 | 2768 |
Missense in Polyphen | 31 | 73.978 | 0.41905 | 825 | ||
Synonymous | 1.99 | 73 | 98.1 | 0.744 | 0.00000576 | 849 |
Loss of Function | 1.87 | 17 | 27.6 | 0.617 | 0.00000156 | 288 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000183 | 0.000178 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000153 | 0.000149 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000198 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May act as a scaffolding protein within caveolar membranes, functionally participating in formation of caveolae or caveolae-like vesicles.;
- Pathway
- Insulin signaling pathway - Homo sapiens (human);Angiopoietin Like Protein 8 Regulatory Pathway;Insulin Signaling;Neuronal System;Synaptic adhesion-like molecules;EGFR1;Protein-protein interactions at synapses
(Consensus)
Recessive Scores
- pRec
- 0.193
Intolerance Scores
- loftool
- 0.529
- rvis_EVS
- -0.52
- rvis_percentile_EVS
- 21.2
Haploinsufficiency Scores
- pHI
- 0.126
- hipred
- Y
- hipred_score
- 0.747
- ghis
- 0.493
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.998
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Flot1
- Phenotype
- hematopoietic system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- membrane raft assembly;positive regulation of cytokine production;positive regulation of protein phosphorylation;regulation of receptor internalization;axonogenesis;extracellular matrix disassembly;positive regulation of protein binding;positive regulation of synaptic transmission, dopaminergic;positive regulation of interferon-beta production;dsRNA transport;positive regulation of heterotypic cell-cell adhesion;positive regulation of toll-like receptor 3 signaling pathway;regulation of toll-like receptor 4 signaling pathway;response to endoplasmic reticulum stress;regulation of Rho protein signal transduction;plasma membrane raft assembly;positive regulation of endocytosis;positive regulation of skeletal muscle tissue development;protein stabilization;protein homooligomerization;regulation of neurotransmitter uptake;positive regulation of cell adhesion molecule production;protein kinase C signaling;cellular response to exogenous dsRNA;protein localization to plasma membrane;positive regulation of myoblast fusion;positive regulation of cell junction assembly;protein localization to membrane raft;positive regulation of cell-cell adhesion mediated by cadherin
- Cellular component
- uropod;lysosomal membrane;endosome;early endosome;microtubule organizing center;plasma membrane;caveola;cell-cell junction;cell-cell adherens junction;focal adhesion;COP9 signalosome;external side of plasma membrane;membrane;basolateral plasma membrane;apical plasma membrane;flotillin complex;lamellipodium;cortical actin cytoskeleton;cytoplasmic vesicle;centriolar satellite;sarcolemma;melanosome;cell-cell contact zone;membrane raft;presynaptic active zone;extracellular exosome;dopaminergic synapse;glutamatergic synapse;GABA-ergic synapse
- Molecular function
- protease binding;protein binding;ionotropic glutamate receptor binding;protein heterodimerization activity